Clinical Trial Update: Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1 [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated shortened zidovudine regimens to prevent mother-to-child transmission of HIV-1. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• RETROVIR (Zidovudine)

Snippet

Sponsor: Institut de Recherche pour le Developpement | Conditions: HIV Infections, Pregnancy | Phase 3 | Status: COMPLETED